Medplus Health Services Limited (MEDPLUS) Share Analysis
NSE · Healthcare · Healthcare
Medplus Health Services Limited (NSE: MEDPLUS) is an Indian listed company in the Healthcare sector and a constituent of NIFTY Microcap 250. As of 21 Sep 2026, the share price was ₹660.00, market capitalisation ₹7,925 Cr, P/E 37.6, ROE 11.6%.
Get the AI verdict on MEDPLUS: BUY, BUY ON DIPS, WAIT or EXIT
Sign in for the full analysis — AI fundamental and technical analysis, recent news, and one verdict with an entry zone, two targets and a stop-loss, for a 3-month, 1-year, 3-year or 5-year horizon. A free plan is available.
Stored fundamentals as of 21 Sep 2026 — not a live quote. Signed-in analysis uses same-day data.
MEDPLUS price and valuation
- Share price
- ₹660.00
- Market cap
- ₹7,925 Cr
- P/E ratio
- 37.6
- P/B ratio
- 4
- EPS
- ₹17.54
- Book value per share
- ₹165.00
- Dividend yield
- 0%
MEDPLUS profitability and growth
- ROE
- 11.6%
- ROCE
- 12.6%
- Debt to equity
- 0.72
- Revenue growth (3 yr)
- 15%
- Revenue growth (5 yr)
- 18%
- Profit growth (3 yr)
- 66%
- Profit growth (5 yr)
- 28%
MEDPLUS 52-week range
- 52-week high
- ₹1,022.20
- 52-week low
- ₹645.00
- Face value
- ₹2.00
MEDPLUS shareholding pattern
- Promoters
- 40.19%
- FIIs
- 14.38%
- DIIs
- 29.95%
- Public
- 15.45%
Index membership: NIFTY Microcap 250.
Learn to read these numbers
- Metrics glossary — what P/E, ROE, ROCE and debt-to-equity mean.
- Investment Blogs — free lessons on fundamental and technical analysis.
- AI stock picks and Discover stocks by sector and index.
- How Stock-Analyze works — what the AI analysis and verdict cover.